Archived Newsletters

  1. 08.01.25 -- CDMOs Should Stop Stringing Biotechs Along 8/1/2025
    08/01/25 Outsourced Pharma Newsletter
  2. 07.31.25 -- Nitrosamine Impurity Detection And Quantification In Sartans And Ranitidine 7/31/2025

    07/31/25 Outsourced Pharma Newsletter

  3. 07.31.25 -- Relationship Equity With CDMOs Is Real, Take It From A Packaging Pro 7/31/2025
    07/31/25 Outsourced Pharma Newsletter
  4. 07.30.25 -- The Biggest Problem At CDMOs Today 7/30/2025
    07/30/25 Outsourced Pharma Newsletter
  5. 07.29.25 -- Exploring Outsourcing's Role In CGT Scalability And Affordability 7/29/2025
    07/29/25 Outsourced Pharma Newsletter
  6. 07.28.25 -- Onshoring Biologics From Discovery To Commercial Drug Product 7/28/2025

    07/28/25 Outsourced Pharma Newsletter

  7. 07.28.25 -- STREAM Edition: Your CDMO Knows A Lot - Are You Listening? 7/28/2025

    07/28/25 Outsourced Pharma Newsletter

  8. 07.28.25 -- CDMOs Should Stop Stringing Biotechs Along 7/28/2025

    07/28/25 Outsourced Pharma Newsletter

  9. 07.25.25 -- Why CDMOs Are Leaving Small Molecules Behind 7/25/2025

    07/25/25 Outsourced Pharma Newsletter

  10. 07.24.25 -- Tools For Smarter Antibody Discovery 7/24/2025

    07/24/25 Outsourced Pharma Newsletter